Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

This is the first study to describe adalimumab pharmacokinetics and the concentration-effect relationship in RA. A 160 mg loading dose may lead to an increased benefit from treatment in RA patients.